Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 85Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Strides Pharma Science

02 2Bal Pharma

03 2Aeon

04 1Dorsa Darou Pharmaceutical Company

05 1Flagship Biotech International Pvt. Ltd

06 1Globela Pharma

07 1Glumex Pharmaceuticals Mfg. Pvt. Ltd

08 1Halewood Laboratories Pvt. Ltd

09 1Holden Medical Laboratories Pvt. Ltd

10 1Infugen Pharma

11 2Lucent Biotech Ltd

12 1MS Pharma

13 2Myungmoon Pharm. Co., LTD.

14 3Opes Health Care

15 3Pharmadax Inc.

16 1Prime Pharmaceuticals

17 1Ram Pharma

18 1Saudi Pharmaceutical Industries & Medical Appliances

19 1Towa Pharma

20 1Umedica Laboratories Pvt Ltd

21 1Vaishali Pharma Ltd

22 1Varichem Pharmaceuticals Pvt Ltd

23 2Vista Pharmaceuticals, Limited.

24 2World Medicine

25 1Xiangbei Welman Pharmaceuticals

26 1Zim Laboratories

27 1Zota Healthcare Ltd

28 4Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Regulatory Info :

Registration Country : India

Glibenclamide

Brand Name :

Dosage Form : Tablet

Dosage Strength : 1.5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Strides Pharma Science

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Packaging :

Regulatory Info :

Glibenclamide

Dosage : Tablet

Dosage Strength : 1.5MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

Strides Pharma Science

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.

Regulatory Info : Generic

Registration Country : India

Glibenclamide

Brand Name : Gluconil

Dosage Form : Tablet

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

BalPharma

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.

Packaging :

Regulatory Info : Generic

Glibenclamide

Dosage : Tablet

Dosage Strength : 5MG

Brand Name : Gluconil

Approval Date :

Application Number :

Registration Country : India

BalPharma

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Regulatory Info :

Registration Country : India

Glibenclamide

Brand Name :

Dosage Form : Tablet

Dosage Strength : 3MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Strides Pharma Science

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Packaging :

Regulatory Info :

Glibenclamide

Dosage : Tablet

Dosage Strength : 3MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

Strides Pharma Science

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Regulatory Info :

Registration Country : India

Glibenclamide

Brand Name :

Dosage Form : Tablet

Dosage Strength : 4.5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Strides Pharma Science

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Packaging :

Regulatory Info :

Glibenclamide

Dosage : Tablet

Dosage Strength : 4.5MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

Strides Pharma Science

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Regulatory Info :

Registration Country : India

Glibenclamide

Brand Name :

Dosage Form : Tablet

Dosage Strength : 6MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Strides Pharma Science

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Packaging :

Regulatory Info :

Glibenclamide

Dosage : Tablet

Dosage Strength : 6MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

Strides Pharma Science

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.

Regulatory Info : Generic

Registration Country : India

Glibenclamide; Metformin

Brand Name : Gluconil M

Dosage Form : Tablet

Dosage Strength : 5MG; 500MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

BalPharma

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.

Packaging :

Regulatory Info : Generic

Glibenclamide; Metformin

Dosage : Tablet

Dosage Strength : 5MG; 500MG

Brand Name : Gluconil M

Approval Date :

Application Number :

Registration Country : India

BalPharma

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Glibenclamide; Sitagliptin Phosphate

Brand Name : AEOMET-GC1

Dosage Form : BILAYERED TABLET

Dosage Strength : 5MG; 850MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Glibenclamide; Sitagliptin Phosphate

Dosage : BILAYERED TABLET

Dosage Strength : 5MG; 850MG

Brand Name : AEOMET-GC1

Approval Date :

Application Number :

Registration Country : India

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Glibenclamide; Sitagliptin Phosphate

Brand Name :

Dosage Form : BILAYERED TABLET

Dosage Strength : 5MG; 500MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Glibenclamide; Sitagliptin Phosphate

Dosage : BILAYERED TABLET

Dosage Strength : 5MG; 500MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Glyburide

Brand Name :

Dosage Form : Tablet

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Glyburide

Brand Name :

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Glyburide

Dosage : TABLET

Dosage Strength : 5MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Glyburide

Brand Name :

Dosage Form : Tablet

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Glyburide

Dosage : Tablet

Dosage Strength : 5MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Glyburide

Brand Name :

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging : Pack Size in UPM - 1000 ,30

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Jordan

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Glyburide

Dosage : TABLET

Dosage Strength : 5MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Jordan

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Metformin Hydrochloride; Glyburide

Brand Name : Metiben

Dosage Form : TABLET

Dosage Strength : 500MG; 2.5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic B.E study

Registration Country : South Korea

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Metformin Hydrochloride; Glyburide

Dosage : TABLET

Dosage Strength : 500MG; 2.5MG

Brand Name : Metiben

Approval Date :

Application Number :

Registration Country : South Korea

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Metformin Hydrochloride; Glyburide

Brand Name : Metiben

Dosage Form : TABLET

Dosage Strength : 500MG; 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic B.E study

Registration Country : South Korea

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Metformin Hydrochloride; Glyburide

Dosage : TABLET

Dosage Strength : 500MG; 5MG

Brand Name : Metiben

Approval Date :

Application Number :

Registration Country : South Korea

blank

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Glyburide

Brand Name :

Dosage Form : Tablet

Dosage Strength : 1.25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Taiwan

blank

15

2024 ACI Convention
Not Confirmed
arrow

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Glyburide

Brand Name :

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging : Blister of 10s

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Glyburide

Dosage : TABLET

Dosage Strength : 5MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Glyburide

Brand Name : Variglyben

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Zimbabwe

blank

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Glyburide

Dosage : TABLET

Dosage Strength : 5MG

Brand Name : Variglyben

Approval Date :

Application Number :

Registration Country : Zimbabwe

blank

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Glyburide

Brand Name :

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Glyburide

Dosage : TABLET

Dosage Strength : 5MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

19

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Glyburide

Brand Name :

Dosage Form : TABLET

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

19

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Glyburide

Dosage : TABLET

Dosage Strength : 10MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

20

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Glyburide; Metformin

Brand Name :

Dosage Form : TABLET

Dosage Strength : 5MG; 500MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

20

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Glyburide; Metformin

Dosage : TABLET

Dosage Strength : 5MG; 500MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank